Alzinova AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alzinova AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11212
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alzinova AB (Alzinova) is a pharmaceutical company that discovers and develops therapeutics for the treatment of Alzheimer’s disease. The company develops amyloid beta CC peptide technology, which offers long-term research and development capabilities including the discovery and development of novel therapeutics, research tools and services. It also develops ALZ-101, an oligomer-directed vaccine; and ALZ-201, a monoclonal antibody used for the treatment of oligomeric amyloid beta. Alzinova offers peptide technology that develops therapeutics against the meta-stable soluble amyloid. The company offers oligomer-directed vaccine and diagnostics based on a monoclonal antibody. It operates through its laboratory located in Goteborg. Alzinova is headquartered in Gothenburg, Sweden.

Alzinova AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alzinova AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alzinova AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Alzinova AB, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Alzinova Raises Funds Through Venture Financing 10
Partnerships 11
Alzinova Enters into Agreement with Clinical Research Services Turku 11
Equity Offering 12
Alzinova Raises USD2 Million in IPO of Units 12
Alzinova Raises USD0.5 Million in Private Placement of Shares 13
Alzinova AB – Key Competitors 14
Alzinova AB – Key Employees 15
Alzinova AB – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Alzinova AB, Pharmaceuticals & Healthcare, Key Facts 2
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alzinova AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alzinova AB, Deals By Therapy Area, 2012 to YTD 2018 8
Alzinova AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Alzinova Raises Funds Through Venture Financing 10
Alzinova Enters into Agreement with Clinical Research Services Turku 11
Alzinova Raises USD2 Million in IPO of Units 12
Alzinova Raises USD0.5 Million in Private Placement of Shares 13
Alzinova AB, Key Competitors 14
Alzinova AB, Key Employees 15
Alzinova AB, Other Locations 16

List of Figures
Alzinova AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alzinova AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alzinova AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Alzinova AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Atterx Biotherapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Atterx Biotherapeutics Inc (Atterx), formerly ConjuGon Inc is a developer of novel products for prevention and treatment of antibiotic-resistant bacterial infections. The company develops and commercializes conjugation-based antibacterial technology. Its products include C-1205 and GN-4474. …
  • Global Business Power Corp:電力:M&Aディール及び事業提携情報
    Summary Global Business Power Corp (GBPC), formerly Mirant Global Corp, a subsidiary of ORIX Corp, is an energy utility that generates and distributes electricity. The utility produces reliable and cost-efficient power supply through its subsidiaries that operate power generation facilities. Its ser …
  • M.M.Warburg & Co Kgaa:企業の戦略・SWOT・財務分析
    M.M.Warburg & Co Kgaa - Strategy, SWOT and Corporate Finance Report Summary M.M.Warburg & Co Kgaa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Advanced Accelerator Applications SA:医療機器:M&Aディール及び事業提携情報
    Summary Advanced Accelerator Applications SA (AAA), a Novartis company, is engaged in developing, producing and commercializing diagnostic and therapeutic molecular nuclear medicine products. The company’s lead product candidate comprises Lutathera, NETSPOT, SOMAKIT TOC, Gluscan, Gluscan 500, Barnas …
  • Amazon.com, Inc.:戦略・SWOT・企業財務分析
    Amazon.com, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amazon.com, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • CryoPort Inc (CYRX)-製薬・医療分野:企業M&A・提携分析
    Summary Cryoport Inc (Cryoport) is a provider of cold chain logistics solutions for temperature-sensitive biological materials to the life science industries. It offers liquid nitrogen dry vapor shippers with advanced logistics management platform called Cryoportal, which provides credentials relate …
  • Rubicon Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Rubicon Genomics Inc (Rubicon Genomics), a subsidiary of the Takara Bio Group is a provider of pre-analytical amplification technologies. The company offers various types of kits for whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing, copy number variation (CNV) …
  • Drax Group Plc (DRX)-エネルギー分野:企業M&A・提携分析
    Summary Drax Group plc (Drax) is a biomass-fuelled electricity generator, which generates electricity from coal and biomass. It operates across three principal areas of activity, electricity generation; electricity sales to business customers; and compressed wood pellet production. The company opera …
  • Shri Lakshmi Cotsyn Ltd.:企業の戦略・SWOT・財務情報
    Shri Lakshmi Cotsyn Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shri Lakshmi Cotsyn Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Delek Group Ltd:戦略・SWOT・企業財務分析
    Delek Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Delek Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Vivimed Labs Ltd (VIVIMEDLAB)-製薬・医療分野:企業M&A・提携分析
    Summary Vivimed Labs Ltd (Vivimed) is a supplier of niche molecules and formulations to healthcare, pharmaceuticals and specialty chemicals customers across the world. The company provides active pharmaceutical ingredients (APIs), finished dosage formulations, and specialty chemicals. It manufacture …
  • Asatsu-DK Inc.:企業の戦略的SWOT分析
    Asatsu-DK Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Rompetrol Rafinare SA (RRC):企業の財務・戦略的SWOT分析
    Rompetrol Rafinare SA (RRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • LGT Bank Ltd.:企業の戦略・SWOT・財務分析
    LGT Bank Ltd. - Strategy, SWOT and Corporate Finance Report Summary LGT Bank Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Heidelberger Druckmaschinen AG:企業の戦略・SWOT・財務分析
    Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report Summary Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • PharmaZell GmbH:企業の戦略的SWOT分析
    PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Spicers Limited (SRS):企業の財務・戦略的SWOT分析
    Spicers Limited (SRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • 3-D Matrix Inc:企業の戦略的SWOT分析
    3-D Matrix Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Faisal Islamic Bank of Egypt (SAE):企業の戦略的SWOT分析
    Faisal Islamic Bank of Egypt (SAE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Nelnet, Inc.:企業のM&A・事業提携・投資動向
    Nelnet, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nelnet, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆